JTV-519 is a 1,4-benzothiazepine derivative researched primarily as a cardioprotective and antiarrhythmic agent. By stabilizing cardiac ryanodine receptors (RyR2) and modulating calcium handling within… Read more
JTV-519 is a 1,4-benzothiazepine derivative researched primarily as a cardioprotective and antiarrhythmic agent. By stabilizing cardiac ryanodine receptors (RyR2) and modulating calcium handling within the sarcoplasmic reticulum, this compound has been studied for its potential to prevent calcium overload, reduce intracellular calcium leaks, and mitigate cardiac arrhythmias. In pharmaceutical analytical settings, the related impurities, metabolites, and stable isotope-labelled compounds in this category are essential tools for method validation, impurity profiling, and quality control. Laboratories rely on these high-quality reference standards to accurately identify and quantify the parent drug and its degradation products in complex matrices, ensuring rigorous adherence to regulatory standards during preclinical and pharmacological research.